Jeil Pharma Holdings Inc. manufactures and sells pharmaceutical ingredients, incrementally modified drugs, and generic drugs in South Korea. Its active pharmaceutical ingredients cover areas such as antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, along with patch products. The company also offers finished dosage forms across categories including anti-bacterial and anti-fungal, anti-viral, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, hepatic, laxatives, and purgatives. It exports to approximately 40 countries, including ASEAN, Central and South America, and Africa, and was founded in 1959 with headquarters in Seoul, South Korea.